TSX Delisting Review - BioExx Specialty Proteins Ltd. (Symbol: BXI)

TORONTO, Oct. 1, 2013 /CNW/ - DELISTING REVIEW  BioExx Specialty Proteins Ltd. (the "Company") - Further to TSX Bulletin #2013-0952 dated September 25, 2013, the common shares of the Company (Symbol: BXI) which are being reviewed with respect to meeting the requirements for continued listing pursuant to the Remedial Review Process, will now be subject to the Expedited Review Process. The common shares are suspended from trading immediately.

About TMX Group (TSX-X)

TMX Group's key subsidiaries operate cash and derivative markets and clearinghouses for multiple asset classes including equities, fixed income and energy. Toronto Stock Exchange, TSX Venture Exchange, TMX Select, Alpha Group, The Canadian Depository for Securities, Montreal Exchange, Canadian Derivatives Clearing Corporation, Natural Gas Exchange, BOX Options Exchange, Shorcan, Shorcan Energy Brokers, Equicom and other TMX Group companies provide listing markets, trading markets, clearing facilities, depository services, data products and other services to the global financial community.  TMX Group is headquartered in Toronto and operates offices across Canada (Montreal, Calgary and Vancouver), in key U.S. markets (New York, Houston, Boston and Chicago) as well as in London, Beijing and Sydney.  For more information about TMX Group, visit our website at www.tmx.com.  Follow TMX Group on Twitter at http://twitter.com/tmxgroup.

SOURCE TMX GROUP INC.